510(k) Report

510(k) · Cleared

Recalled · 2003

Rianen Angiotensin I Radioimmunoassay KI

K850054510(k) TraditionalCleared Mar 29, 198580-day reviewClass II21 CFR 862.1085Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

E.I. Dupont DE Nemours & Co., Inc. · CIB Radioimmunoassay, Angiotensin I And Renin

Cleared on Mar 29, 1985 after an 80-day review. FDA has not posted a summary or statement for it, so its predicates are not known. It has been recalled 2 times.

Decided
Mar 29, 1985
Review
80 days
Class
Class II
Product code
CIB
Recalls
2
Predicates
0

FDA has not posted a summary or statement for it, so its predicates are not known.

FIG. 1 — Lineage of K850054Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CIB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 28, 2003Not classifiedZ-1207-03OtherIncorrect calibration standard value may result in 25% higher assay values for controls and patient samples
Jul 28, 2003Not classifiedZ-1206-03OtherIncorrect calibration standard value may result in 25% higher assay values for controls and patient samples

No ancestor or descendant has a Class I recall.

How does its category compare?

All CIB devices

CIB Radioimmunoassay, Angiotensin I And Renin: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CIB

2in 2013

2007: 12013: 2
2007high 2 (2013) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CIB

Too few CIB 510(k)s in any year since 2007 to give a median.

Recalls per year · CIB

1in 2012

2009: 12012: 1
2007high 1 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CIB

No MAUDE report names CIB since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20090—10
20100—00
20110—00
20120—10
20132—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—
Cite this page

510(k) Report. “K850054: Rianen Angiotensin I Radioimmunoassay KI.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K850054

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026